Crry/p65 Antikörper

Produktnummer ABIN2689475

Dieser Ratte Monoklonal Antikörper detektiert spezifisch Crry/p65 in Func, IHC (fro), FACS, IHC (zinc), IHC (p) und ELISA. Es zeigt Reaktivität gegenüber Proben von Maus. Es wurde in 4+ Publikationen zitiert.

Kurzübersicht für Crry/p65 Antikörper (ABIN2689475)

Target: Crry/p65

Reaktivität: Maus

Wirt: Ratte

Klonalität: Monoklonal

Applikation: Functional Studies (Func), Immunohistochemistry (Frozen Sections) (IHC (fro)), Flow Cytometry (FACS), Immunohistochemistry (Zinc-fixed Sections) (IHC (zinc)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), ELISA

Klon: 1F2

Produktdetails

Produktmerkmale: The 1F2 mAb reacts with Crry/p65, a cell-surface protein that blocks complement activation and C3 deposition by both the classical and alternative pathways. Based on nucleotide sequence identity, Crry/p65 is the genetic homologue of human CR1 (Complement Receptor 1). However, it has been proposed that Crry/p65 is the functional homologue of human MCP (Membrane Cofactor Protein) and/or DAF (Decay-Accelerating Factor), due to the similar functions these proteins share and the fact that Crry/p65 does not display CR1's complement-receptor activity. Crry/p65 is expressed in most organs, such as thymus, kidney, uterus, skin, lung, pancreas, heart, stomach, large and small intestine, and spleen. Platelets, brain, and muscle express low, but detectable levels of Crry/p65. In addition, Crry/p65 is expressed in J774 cells, bone marrow-derived macrophages, and thioglycollate-elicited peritoneal macrophages, as determined by RT-PCR. Crry is crucial in the regulation of complement activation during early mouse embryonic development and essential in fetomaternal tolerance. The 1F2 mAb partially blocks Crry/p65-mediated complement protection in vitro.

BD Pharmingen™ Purified Rat Anti-Mouse Crry/p65 - Purified - Clone 1F2 - Isotype Rat IgG2a, κ - Reactivity Ms - 0.1 mg

Aufreinigung: The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Immunogen: Recombinant soluble Crry/p65 protein

Isotyp: IgG2a kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.5 mg/mL

Buffer: Aqueous buffered solution containing ≤0.09 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Store undiluted at 4° C and protected from prolonged exposure to light. Do not freeze.

Referenzen

Xu, Mao, Holers, Palanca, Cheng, Molina: "A critical role for murine complement regulator crry in fetomaternal tolerance." in: Science (New York, N.Y.), Vol. 287, Issue 5452, pp. 498-501, (2000) (PubMed).

Foley, Li, Dehoff, Molina, Holers: "Mouse Crry/p65 is a regulator of the alternative pathway of complement activation." in: European journal of immunology, Vol. 23, Issue 6, pp. 1381-4, (1993) (PubMed).

Martin, Weis: "Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products." in: European journal of immunology, Vol. 23, Issue 11, pp. 3037-42, (1993) (PubMed).

Holers, Kinoshita, Molina: "The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function." in: Immunology today, Vol. 13, Issue 6, pp. 231-6, (1992) (PubMed).

Antigendetails

Target: Crry/p65

Andere Bezeichnung: Crry,p65